NEW YORK, March 20, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding
Citigroup, Inc. (NYSE: C), JPMorgan Chase & Co. (NYSE: JPM),
Morgan Stanley (NYSE: MS), State Street Corp. (NYSE: STT), and
NorthStar Realty Finance Corp. (NYSE: NRF). Private wealth members
receive these notes ahead of publication. To reserve complementary
membership, limited openings are available at:
http://www.AnalystsReview.com/register
--
Citigroup, Inc. Analyst Notes
On March 14, 2014, Citigroup, Inc.
(Citi) announced that it will issue the press release of its Q1
2014 results on April 14, 2014, at
8:00 a.m. ET. Further, the results
will be reviewed via live webcast and teleconference at
11:00 a.m. ET on the same day. Citi
stated that the earnings press release, webcast and presentation
materials will be available at its website, where a replay and
transcript of the webcast will also be made available shortly after
the event. The full analyst notes on Citigroup, Inc. are available
to download free of charge at:
http://www.AnalystsReview.com/03202014/C/report.pdf
--
JPMorgan Chase & Co. Analyst Notes
On March 14, 2014, JPMorgan Chase
& Co. (JPMorgan Chase) declared dividends on two of its
preferred stock issues. The Company announced dividends in the
amount of $395.00 per share
(equivalent to $39.50 per related
Depositary Share) on its Fixed-to-Floating Rate Non-Cumulative
Preferred Stock, Series I; and in the amount of $257.50 per share (equivalent to $25.75 per related Depositary Share)
Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series Q.
JPMorgan Chase informed that the Series I dividend is payable on
April 30, 2014, to stockholders of
record as of the close of business on March
31, 2014, and that the Series Q dividend is payable on
May 1, 2014, to Company stockholders
of record as of the close of business on April 1, 2014. The full analyst notes on JPMorgan
Chase & Co. are available to download free of charge at:
http://www.AnalystsReview.com/03202014/JPM/report.pdf
--
Morgan Stanley Analyst Notes
On March 11, 2014, Morgan Stanley
announced that it has appointed Lisa M.
Cregan as the Mid-Atlantic Regional Director for Morgan
Stanley Wealth Management, based in Washington, D.C. According to the Company, the
region includes six complexes and 40 branch offices stretching from
Northern Virginia to Northern Ohio. Cregan will report to
Richard Skae, Northeast Division
Director, who said, "Lisa Cregan is
an accomplished leader - passionate about serving clients,
developing the professional skills of our people and advancing
women in finance. She will do an excellent job leading our
Mid-Atlantic Region." The full analyst notes on Morgan Stanley are
available to download free of charge at:
http://www.AnalystsReview.com/03202014/MS/report.pdf
--
State Street Corp. Analyst Notes
On March 10, 2014, State Street
Corp. (State Street) announced that two of its senior executives,
Suresh Krishnamurthy and
Cesar Estrada, have been appointed
to its Alternatives Investment Solutions' (AIS) North American
Private Equity Fund Services team, and will lead teams dedicated to
servicing alternative fund of funds, limited partner, direct and
hybrid structures. According to the Company, both are senior
managing directors and will report to Bhagesh Malde, Head of Private Equity and Real
Estate Fund Services for North
America and Asia Pacific.
Commenting on the appointments, Malde stated, "We're focused on
providing dedicated teams and sophisticated data and analytics
tools to help managers satisfy these growing demands, boost
performance and manage risk more effectively. Cesar and Suresh's
teams will focus on supporting our clients as they adapt to this
changing environment." The full analyst notes on State Street Corp.
are available to download free of charge at:
http://www.AnalystsReview.com/03202014/STT/report.pdf
--
NorthStar Realty Finance Corp. Analyst Notes
On March 17, 2014, NorthStar
Realty Finance Corp. (NorthStar) announced that it has entered into
a definitive agreement to acquire a $1.05
billion healthcare real estate portfolio from investment
partnerships owned and managed by Formation Capital, LLC or its
affiliated entities and Safanad Limited. According to NorthStar,
the portfolio consists of 43 primarily private-pay senior housing
facilities and 37 skilled nursing facilities with approximately
$1.6 billion healthcare real estate
portfolio consisting of over 160 properties. Commenting on the
agreement, David Hamamoto, Chairman
and CEO of NorthStar, stated, "We are very pleased to have a
diversified, quality portfolio of healthcare properties added to
our existing healthcare portfolio that we expect will produce
attractive current and overall returns. Since joining our
healthcare real estate team only two months ago, Jay Flaherty has sourced an investment pipeline
through his relationships in the industry that is adding
significant value to the NorthStar franchise." The full analyst
notes on NorthStar Realty Finance Corp. are available to download
free of charge at:
http://www.AnalystsReview.com/03202014/NRF/report.pdf
--
About Analysts Review
We provide our members with a simple and reliable way to leverage
our economy of scale. Most investors do not have time to track all
publicly traded companies, much less perform an in-depth review and
analysis of the complexities contained in each situation. That's
where Analysts Review comes in. We provide a single unified
platform for investors' to hear about what matters. Situation
alerts, moving events, and upcoming opportunities.
--
=============
EDITOR NOTES:
- This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
- This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
- If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] AnalystsReview.com.
-
For any urgent concerns or inquiries,
please contact us at compliance [at] AnalystsReview.com.
- Are you a public company? Would you like to see similar
coverage on your company? Send us a full investors' package to
research [at] AnalystsReview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort
basis. This document, article or report is prepared and authored by
Analysts Review. An outsourced research services provider
represented by Nidhi Vatsal, CFA, has only reviewed the information
provided by Analysts Review in this article or report according to
the Procedures outlined by Analysts Review. Analysts Review is not
entitled to veto or interfere in the application of such procedures
by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to
the accuracy or completeness or fitness for a purpose (investment
or otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Analysts Review
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Analysts Review expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Analysts Review does not (1)
guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute
SOURCE Analysts Review